ALLIANCEBERNSTEIN L.P. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,321,578
-67.1%
113,052
-62.2%
0.00%
-50.0%
Q2 2023$4,019,662
+77.5%
299,082
+118.9%
0.00%
+100.0%
Q1 2023$2,265,193
-19.2%
136,622
-9.4%
0.00%0.0%
Q4 2022$2,804,006
+41.3%
150,753
-2.6%
0.00%0.0%
Q3 2022$1,985,000
-45.3%
154,699
-70.1%
0.00%
-50.0%
Q2 2022$3,629,000
+225.8%
517,711
+285.2%
0.00%
Q1 2022$1,114,000
+22.8%
134,400
+0.4%
0.00%
Q4 2021$907,000
+27.7%
133,9000.0%0.00%
Q3 2021$710,000
-13.0%
133,900
-5.7%
0.00%
Q2 2021$816,000
+24.8%
141,9480.0%0.00%
Q1 2021$654,000
+24.8%
141,948
-9.5%
0.00%
Q4 2020$524,000
+18.6%
156,787
+5.4%
0.00%
Q3 2020$442,000
-35.7%
148,8000.0%0.00%
Q2 2020$687,000
+19.9%
148,8000.0%0.00%
Q1 2020$573,000
+2.7%
148,8000.0%0.00%
Q4 2019$558,000
-29.4%
148,8000.0%0.00%
Q3 2019$790,000
+38.4%
148,8000.0%0.00%
Q2 2019$571,000
+25.8%
148,800
+67.0%
0.00%
Q1 2019$454,000
+410.1%
89,100
+91.6%
0.00%
Q4 2018$89,000
-35.5%
46,500
+27.7%
0.00%
Q3 2018$138,000
+51.6%
36,400
+24.7%
0.00%
Q2 2018$91,000
+116.7%
29,200
+65.0%
0.00%
Q1 2018$42,000
+2.4%
17,700
+70.2%
0.00%
Q4 2017$41,000
+36.7%
10,400
-11.9%
0.00%
Q3 2017$30,000
-9.1%
11,8000.0%0.00%
Q2 2017$33,000
+3200.0%
11,800
+3141.8%
0.00%
Q1 2014$1,0000.0%3640.0%0.00%
Q4 2013$1,0000.0%3640.0%0.00%
Q3 2013$1,0003640.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders